(cid:16)(cid:27)(cid:21)(cid:29)(cid:20)(cid:24)(cid:23)(cid:26)(cid:1)(cid:17)(cid:26)(cid:30)(cid:22)(cid:25)(cid:27)(cid:28)(cid:22)(cid:1)(cid:19)(cid:16)(cid:12)(cid:1)(cid:4)(cid:10)(cid:16)(cid:18)(cid:5)(cid:4)(cid:4)(cid:14)(cid:2)(cid:15)(cid:6)(cid:14)(cid:3)(cid:2)(cid:7)(cid:15)(cid:17)(cid:10)(cid:2)(cid:11)(cid:16)(cid:6)(cid:15)(cid:2)(cid:3)(cid:18)(cid:13)(cid:9)(cid:18)(cid:5)(cid:6)(cid:8)(cid:17)(cid:14)(cid:17)(cid:3)
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`__________________________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`__________________________________
`
`FORESIGHT DIAGNOSTICS INC.,
`Petitioner,
`
`v.
`
`PERSONALIS, INC.,
`Patent Owner.
`
`Case Nos. IPR2023-00224 and IPR2023-00317
`U.S. Patent Nos. 11,384,394 and 11,408,033
`
`DECLARATION OF JONATHAN MACQUITTY
`
`Personalis EX2033
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`__________________________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`__________________________________
`
`FORESIGHT DIAGNOSTICS INC.,
`Petitioner,
`
`v.
`
`PERSONALIS, INC.,
`Patent Owner.
`
`Case Nos. IPR2023-00224 and IPR2023-00317
`U.S. Patent Nos. 11,384,394 and 11,408,033
`
`DECLARATION OF JONATHAN MACQUITTY
`
`Personalis EX2033
`
`
`
`(cid:16)(cid:27)(cid:21)(cid:29)(cid:20)(cid:24)(cid:23)(cid:26)(cid:1)(cid:17)(cid:26)(cid:30)(cid:22)(cid:25)(cid:27)(cid:28)(cid:22)(cid:1)(cid:19)(cid:16)(cid:12)(cid:1)(cid:4)(cid:10)(cid:16)(cid:18)(cid:5)(cid:4)(cid:4)(cid:14)(cid:2)(cid:15)(cid:6)(cid:14)(cid:3)(cid:2)(cid:7)(cid:15)(cid:17)(cid:10)(cid:2)(cid:11)(cid:16)(cid:6)(cid:15)(cid:2)(cid:3)(cid:18)(cid:13)(cid:9)(cid:18)(cid:5)(cid:6)(cid:8)(cid:17)(cid:14)(cid:17)(cid:3)
`
`TABLE OF CONTENTS
`
`Page No.
`
`(cid:3) I
`
`. BACKGROUND AND QUALIFICATIONS ........................................................ 1(cid:3)
`II. BOARD OF DIRECTOR MEETINGS AT PERSONALIS ................................. 3(cid:3)
`A.(cid:3)
`Summary of the July 26, 2011 Personalis Board of Director Meeting . 3(cid:3)
`B.(cid:3)
`Summary of the May 8, 2012 Personalis Board of Director Meeting .. 4(cid:3)
`C.(cid:3)
`Summary of the June 12, 2012 Personalis Board of Director Meeting 6(cid:3)
`D.(cid:3)
`Summary of the July 18, 2012 Personalis Board of Director Meeting . 7(cid:3)
`E.(cid:3)
`Summary of the September 5, 2012 Personalis Board of Director
`Meeting ............................................................................................................ 8(cid:3)
`F.(cid:3)
`Summary of the November 1, 2012 Personalis Board of Director
`Meeting ............................................................................................................ 9(cid:3)
`G.(cid:3)
`Summary of the December 14, 2012 Personalis Board of Director
`Meeting .......................................................................................................... 10(cid:3)
`III. CERTIFICATION ............................................................................................. 12(cid:3)
`
`Table of Contents, Page 1
`
`Personalis EX2033
`
`
`
`(cid:16)(cid:27)(cid:21)(cid:29)(cid:20)(cid:24)(cid:23)(cid:26)(cid:1)(cid:17)(cid:26)(cid:30)(cid:22)(cid:25)(cid:27)(cid:28)(cid:22)(cid:1)(cid:19)(cid:16)(cid:12)(cid:1)(cid:4)(cid:10)(cid:16)(cid:18)(cid:5)(cid:4)(cid:4)(cid:14)(cid:2)(cid:15)(cid:6)(cid:14)(cid:3)(cid:2)(cid:7)(cid:15)(cid:17)(cid:10)(cid:2)(cid:11)(cid:16)(cid:6)(cid:15)(cid:2)(cid:3)(cid:18)(cid:13)(cid:9)(cid:18)(cid:5)(cid:6)(cid:8)(cid:17)(cid:14)(cid:17)(cid:3)
`
`LIST OF EXHIBITS CITED
`
`Exhibit No.
`
`Description
`
`2110
`
`2043
`
`2064
`
`2073
`
`2087
`
`2111
`
`2107
`
`2112
`
`Minutes of the Meeting of the Board of Directors of Personalis,
`Inc. held on July 26, 2011
`
`Minutes of the Meeting of the Board of Directors of Personalis,
`Inc. held on May 8, 2012
`
`Minutes of the Meeting of the Board of Directors of Personalis,
`Inc. held on June 12, 2012
`
`Minutes of the Meeting of the Board of Directors of Personalis,
`Inc. held on July 18, 2012
`
`Minutes of the Meeting of the Board of Directors of Personalis,
`Inc. held on September 5, 2012
`
`Minutes of the Meeting of the Board of Directors of Personalis,
`Inc. held on November 1, 2012
`
`Minutes of the Meeting of the Board of Directors of Personalis,
`Inc. held on December 14, 2012
`
`May 8, 2012 CEO Overview Board of Director Presentation by
`John West
`
`Exhibit List, Page 1
`
`Personalis EX2033
`
`
`
`(cid:16)(cid:27)(cid:21)(cid:29)(cid:20)(cid:24)(cid:23)(cid:26)(cid:1)(cid:17)(cid:26)(cid:30)(cid:22)(cid:25)(cid:27)(cid:28)(cid:22)(cid:1)(cid:19)(cid:16)(cid:12)(cid:1)(cid:4)(cid:10)(cid:16)(cid:18)(cid:5)(cid:4)(cid:4)(cid:14)(cid:2)(cid:15)(cid:6)(cid:14)(cid:3)(cid:2)(cid:7)(cid:15)(cid:17)(cid:10)(cid:2)(cid:11)(cid:16)(cid:6)(cid:15)(cid:2)(cid:3)(cid:18)(cid:13)(cid:9)(cid:18)(cid:5)(cid:6)(cid:8)(cid:17)(cid:14)(cid:17)(cid:3)
`
`Foresight Diagnostics v. Personalis
`IPR2023-00224 and IPR2023-00317
`1.
`I, Jonathan MacQuitty, Ph.D., make this Declaration in connection with
`
`inter partes review proceedings at the U.S. Patent & Trademark Office concerning
`
`U.S. Patent No. 11,384,394 (“the ’394 patent”) and U.S. Patent No. 11,408,033
`
`(“the ’033 patent”).
`
`2.
`
`This declaration provides a summary of certain Personalis Board of
`
`Director meetings that occurred between July of 2011 and December 2012.
`
`I. BACKGROUND AND QUALIFICATIONS
`3.
`I am a Venture Partner at Lightspeed Management Company, LLC. I
`
`have held this role from 2016 until present. Lightspeed has invested in many life
`
`science companies.
`
`4.
`
`I served as the Chairman of the Board of Directors at Personalis from
`
`2011 until 2022. I have served as a Board Member at Labcyte, TeneoBio, Orca Bio,
`
`Freespira, Forty Seven, Adiana, Dicerna, Entelos, Guava, Gynesonics, Iconix,
`
`ParAllele BioScience, SJF Pharma, and Sunesis Pharmaceuticals.
`
`5.
`
`I served as the Chief Executive Officer of D2G Oncology, Inc. from
`
`2018 until 2022. D2G Oncology leverages quantitative and multiplexed functional
`
`cancer genomics to relate drugs to genotypes to transform precision cancer
`
`therapeutics.
`
`6.
`
`I served as Chief Executive Officer of Forty Seven, Inc. from 2015 until
`
`2017. Forty Seven was committed to the advancement of immune-oncology through
`
`-1-
`
`Personalis EX2033
`
`
`
`(cid:16)(cid:27)(cid:21)(cid:29)(cid:20)(cid:24)(cid:23)(cid:26)(cid:1)(cid:17)(cid:26)(cid:30)(cid:22)(cid:25)(cid:27)(cid:28)(cid:22)(cid:1)(cid:19)(cid:16)(cid:12)(cid:1)(cid:4)(cid:10)(cid:16)(cid:18)(cid:5)(cid:4)(cid:4)(cid:14)(cid:2)(cid:15)(cid:6)(cid:14)(cid:3)(cid:2)(cid:7)(cid:15)(cid:17)(cid:10)(cid:2)(cid:11)(cid:16)(cid:6)(cid:15)(cid:2)(cid:3)(cid:18)(cid:13)(cid:9)(cid:18)(cid:5)(cid:6)(cid:8)(cid:17)(cid:14)(cid:17)(cid:3)
`
`Foresight Diagnostics v. Personalis
`IPR2023-00224 and IPR2023-00317
`the engagement of new and complementary phagocytic pathways that enhance anti-
`
`tumor efficacy and selectivity. Forty Seven completed an initial public offering in
`
`2018, and was subsequently acquired by Gilead Sciences, Inc. in 2020 for $4.9
`
`billion.
`
`7.
`
`I was a Partner at Abingworth Management Inc. from 1999 until 2014.
`
`Abingworth is a trans-Atlantic bio-investment firm.
`
`8.
`
`I was the US representative of a Japanese venture capital firm from
`
`1997 until 1999.
`
`9.
`
`I was the founding Chief Executive Officer of GenPharm International.
`
`I was the CEO of GenPharm from 1988 to 1997. GenPharm was a biotechnology
`
`company developing a human sequence antibody platform among other projects.
`
`10.
`
`I helped launch Genencor Inc. as an independent company. Genencor
`
`was a joint venture between Genentech and Corning Glass Works that focused on
`
`industrial enzymes. I was the director of business development from 1983 to 1985,
`
`and the vice president of commercial development from 1985 to 1988.
`
`11.
`
`I was the manager of industrial products at Genentech, Inc. from 1982
`
`to 1983.
`
`12.
`
`I earned a Masters of Business Administration from Stanford
`
`University in 1982.
`
`13.
`
`I earned a Ph.D. in Chemistry from the University of Sussex in 1979.
`
`-2-
`
`Personalis EX2033
`
`
`
`(cid:16)(cid:27)(cid:21)(cid:29)(cid:20)(cid:24)(cid:23)(cid:26)(cid:1)(cid:17)(cid:26)(cid:30)(cid:22)(cid:25)(cid:27)(cid:28)(cid:22)(cid:1)(cid:19)(cid:16)(cid:12)(cid:1)(cid:4)(cid:10)(cid:16)(cid:18)(cid:5)(cid:4)(cid:4)(cid:14)(cid:2)(cid:15)(cid:6)(cid:14)(cid:3)(cid:2)(cid:7)(cid:15)(cid:17)(cid:10)(cid:2)(cid:11)(cid:16)(cid:6)(cid:15)(cid:2)(cid:3)(cid:18)(cid:13)(cid:9)(cid:18)(cid:5)(cid:6)(cid:8)(cid:17)(cid:14)(cid:17)(cid:3)
`
`Foresight Diagnostics v. Personalis
`IPR2023-00224 and IPR2023-00317
`14.
`I earned a Masters of Art in Chemistry from Oxford University in 1974.
`
`II. BOARD OF DIRECTOR MEETINGS AT PERSONALIS
`15. As mentioned above, I served as Chairman of the Board of Directors at
`
`Personalis from 2011 until 2022. This declaration provides a summary of the
`
`Personalis Board of Director meetings that took place on the following dates:
`
`(cid:120) July 26, 2011,
`
`(cid:120) May 8, 2012,
`
`(cid:120) June 12, 2012,
`
`(cid:120) July 18, 2012,
`
`(cid:120) September 5, 2012,
`
`(cid:120) November 1, 2012, and
`
`(cid:120) December 14, 2012.
`
`A.
`
`Summary of the July 26, 2011 Personalis Board of Director Meeting
`
`16. Exhibit 2110 appears to be a true and correct copy of the Minutes of the
`
`Meeting of the Board of Directors of Personalis, Inc. held on July 26, 2011. The
`
`meeting took place at 10:30am at Mohr Davidow Venture’s office at 3000 Sand Hill
`
`Road, Building 3, Suite 290, Menlo Park, CA. See July 26, 2011 Meeting Minutes,
`
`EX2110, at page 1.
`
`17.
`
`I was present at the meeting along with Sue Siegel of Mohr Davidow
`
`Ventures and Andrew Chung of Lightspeed Venture Partners. Also present were
`
`-3-
`
`Personalis EX2033
`
`
`
`(cid:16)(cid:27)(cid:21)(cid:29)(cid:20)(cid:24)(cid:23)(cid:26)(cid:1)(cid:17)(cid:26)(cid:30)(cid:22)(cid:25)(cid:27)(cid:28)(cid:22)(cid:1)(cid:19)(cid:16)(cid:12)(cid:1)(cid:4)(cid:10)(cid:16)(cid:18)(cid:5)(cid:4)(cid:4)(cid:14)(cid:2)(cid:15)(cid:6)(cid:14)(cid:3)(cid:2)(cid:7)(cid:15)(cid:17)(cid:10)(cid:2)(cid:11)(cid:16)(cid:6)(cid:15)(cid:2)(cid:3)(cid:18)(cid:13)(cid:9)(cid:18)(cid:5)(cid:6)(cid:8)(cid:17)(cid:14)(cid:17)(cid:3)
`
`Foresight Diagnostics v. Personalis
`IPR2023-00224 and IPR2023-00317
`John West, Russ Altman, Euan Ashley, and Mike Snyder (although Drs. Altman,
`
`Ashley, and Snyder participated for only a portion of the meeting). Others present
`
`were Robin Bennett of Cooley LLP, Lisa Kenkel of Fenwick & West LLP, and Alex
`
`de Winter of Mohr Davidow Ventures. See July 26, 2011 Meeting Minutes,
`
`EX2110, at page 1.
`
`18.
`
`John West was the chairman of the meeting. See July 26, 2011 Meeting
`
`Minutes, EX2110, at page 3.
`
`19.
`
`The Minutes of the Meeting state that Dr. Ashley gave a presentation
`
`“on the research developments regarding whole genome sequencing and discussed
`
`publishing opportunities.” See July 26, 2011 Meeting Minutes, EX2110, at page 2.
`
`B.
`
`Summary of the May 8, 2012 Personalis Board of Director Meeting
`
`20.
`
`Exhibit 2043 appears to be a true and correct copy of all three pages of
`
`the Minutes of the Meeting of the Board of Directors of Personalis, Inc. held on May
`
`8, 2012. However, Exhibit 2043 does not include Exhibit A to the Minutes of the
`
`Meeting (which consists of a single page) because Exhibit A solely describes the
`
`confidential grant of Personalis stock options to certain new employees hired to work
`
`at Personalis.
`
`21.
`
`The May 8, 2012 Board of Director Meeting took place at 1:00pm at
`
`the company office of Personalis located at 530 Lytton Avenue, Palo Alto, CA. See
`
`May 8, 2012 Meeting Minutes, EX2043, at page 1.
`
`-4-
`
`Personalis EX2033
`
`
`
`(cid:16)(cid:27)(cid:21)(cid:29)(cid:20)(cid:24)(cid:23)(cid:26)(cid:1)(cid:17)(cid:26)(cid:30)(cid:22)(cid:25)(cid:27)(cid:28)(cid:22)(cid:1)(cid:19)(cid:16)(cid:12)(cid:1)(cid:4)(cid:10)(cid:16)(cid:18)(cid:5)(cid:4)(cid:4)(cid:14)(cid:2)(cid:15)(cid:6)(cid:14)(cid:3)(cid:2)(cid:7)(cid:15)(cid:17)(cid:10)(cid:2)(cid:11)(cid:16)(cid:6)(cid:15)(cid:2)(cid:3)(cid:18)(cid:13)(cid:9)(cid:18)(cid:5)(cid:6)(cid:8)(cid:17)(cid:14)(cid:17)(cid:3)
`
`Foresight Diagnostics v. Personalis
`IPR2023-00224 and IPR2023-00317
`22.
`I was present at the meeting along with Chris Schaepe of Lightspeed
`
`Venture Partners. Also present from Personalis were John West, Carol Tillis,
`
`Richard Chen, and Christian Haudenschild. Others present were James C. Kitch of
`
`Cooley LLP and Alex de Winter of Mohr Davidow Ventures. See May 8, 2012
`
`Meeting Minutes, EX2043, at page 1.
`
`23.
`
`I was the chairman of the meeting. See May 8, 2012 Meeting Minutes,
`
`EX2043, at page 3.
`
`24. The Minutes of the Meeting state that “[m]embers of management
`
`reported on, and discussed with those present, progress in the development of the
`
`Company’s business, planning for 2012 and 2013, recent financial performance
`
`compared to the original plan and preliminary strategy for the Company’s next
`
`financing.” See May 8, 2012 Meeting Minutes, EX2043, at page 1.
`
`25. Mr. West gave his CEO Overview presentation during the meeting, as
`
`he did during each of the Board of Director meetings that I attended. I remember
`
`hearing Mr. West’s presentation during the May 8, 2012 meeting. This included a
`
`discussion of the Accuracy Program. The Accuracy Program was the most
`
`important technical program at Personalis at that time. To the best of recollection,
`
`Exhibit 2112 appears to be a true and correct copy of the slides presented by Mr.
`
`West during the meeting.
`
`26. Dr. Chen gave his R&D Update presentation during the meeting.
`
`-5-
`
`Personalis EX2033
`
`
`
`(cid:16)(cid:27)(cid:21)(cid:29)(cid:20)(cid:24)(cid:23)(cid:26)(cid:1)(cid:17)(cid:26)(cid:30)(cid:22)(cid:25)(cid:27)(cid:28)(cid:22)(cid:1)(cid:19)(cid:16)(cid:12)(cid:1)(cid:4)(cid:10)(cid:16)(cid:18)(cid:5)(cid:4)(cid:4)(cid:14)(cid:2)(cid:15)(cid:6)(cid:14)(cid:3)(cid:2)(cid:7)(cid:15)(cid:17)(cid:10)(cid:2)(cid:11)(cid:16)(cid:6)(cid:15)(cid:2)(cid:3)(cid:18)(cid:13)(cid:9)(cid:18)(cid:5)(cid:6)(cid:8)(cid:17)(cid:14)(cid:17)(cid:3)
`
`Foresight Diagnostics v. Personalis
`IPR2023-00224 and IPR2023-00317
`C.
`Summary of the June 12, 2012 Personalis Board of Director Meeting
`
`27. Exhibit 2064 appears to be a true and correct copy of all three pages of
`
`the Minutes of the Meeting of the Board of Directors of Personalis, Inc. held on June
`
`12, 2012. However, Exhibit 2064 does not include Exhibit A to the Minutes of the
`
`Meeting (which consists of a single page) because Exhibit A solely describes the
`
`confidential grant of Personalis stock options to a certain new employee hired to
`
`work at Personalis.
`
`28. The June 12, 2012 Board of Director Meeting took place at 1:30pm at
`
`the company office of Personalis located at 530 Lytton Avenue, Palo Alto, CA. See
`
`June 12, 2012 Meeting Minutes, EX2064, at page 1.
`
`29.
`
`I was present at the meeting along with Chris Schaepe of Lightspeed
`
`Venture Partners and Rowan Chapman of Mohr Davidow Ventures. Also present
`
`from Personalis were John West, Carol Tillis, Richard Chen, and Christian
`
`Haudenschild. Others present were James C. Kitch of Cooley LLP and Alex de
`
`Winter of Mohr Davidow Ventures. See June 12, 2012 Meeting Minutes, EX2064,
`
`at page 1.
`
`30.
`
`I was the chairman of the meeting. See June 12, 2012 Meeting Minutes,
`
`EX2064, at page 3.
`
`31. The Minutes of the Meeting state that “[m]embers of management
`
`reported on, and discussed with those present, progress in the development of the
`
`-6-
`
`Personalis EX2033
`
`
`
`(cid:16)(cid:27)(cid:21)(cid:29)(cid:20)(cid:24)(cid:23)(cid:26)(cid:1)(cid:17)(cid:26)(cid:30)(cid:22)(cid:25)(cid:27)(cid:28)(cid:22)(cid:1)(cid:19)(cid:16)(cid:12)(cid:1)(cid:4)(cid:10)(cid:16)(cid:18)(cid:5)(cid:4)(cid:4)(cid:14)(cid:2)(cid:15)(cid:6)(cid:14)(cid:3)(cid:2)(cid:7)(cid:15)(cid:17)(cid:10)(cid:2)(cid:11)(cid:16)(cid:6)(cid:15)(cid:2)(cid:3)(cid:18)(cid:13)(cid:9)(cid:18)(cid:5)(cid:6)(cid:8)(cid:17)(cid:14)(cid:17)(cid:3)
`
`Foresight Diagnostics v. Personalis
`IPR2023-00224 and IPR2023-00317
`Company’s business, recent financial results compared to plan, plans for the
`
`Company’s new facility, capital spending requirements and operations and R&D
`
`updates.” See June 12, 2012 Meeting Minutes, EX2064, at page 1. Mr. West gave
`
`his CEO Overview presentation during the meeting. Dr. Chen gave his R&D Update
`
`presentation during the meeting.
`
`D.
`
`Summary of the July 18, 2012 Personalis Board of Director Meeting
`
`32.
`
`Exhibit 2073 appears to be a true and correct copy of all three pages of
`
`the Minutes of the Meeting of the Board of Directors of Personalis, Inc. held on July
`
`18, 2012. However, Exhibit 2073 does not include Exhibit A to the Minutes of the
`
`Meeting (which consists of a single page) because Exhibit A solely describes the
`
`confidential grant of Personalis stock options to certain new employees hired to work
`
`at Personalis.
`
`33.
`
`The July 18, 2012 Board of Director Meeting took place at 1:30pm at
`
`the company office of Personalis located at 1350 Willow Road, Suite 202, Menlo
`
`Park, CA. See July 18, 2012 Meeting Minutes, EX2073, at page 1.
`
`34.
`
`I was present at the meeting along with Rowan Chapman of Mohr
`
`Davidow Ventures. Chris Schaepe of Lightspeed Venture Partners was present in
`
`person for a portion of the meeting and by telephone for a portion of the meeting.
`
`Also present from Personalis were John West, Carol Tillis, Richard Chen, and
`
`Christian Haudenschild. Others present were James C. Kitch of Cooley LLP and
`
`-7-
`
`Personalis EX2033
`
`
`
`(cid:16)(cid:27)(cid:21)(cid:29)(cid:20)(cid:24)(cid:23)(cid:26)(cid:1)(cid:17)(cid:26)(cid:30)(cid:22)(cid:25)(cid:27)(cid:28)(cid:22)(cid:1)(cid:19)(cid:16)(cid:12)(cid:1)(cid:4)(cid:10)(cid:16)(cid:18)(cid:5)(cid:4)(cid:4)(cid:14)(cid:2)(cid:15)(cid:6)(cid:14)(cid:3)(cid:2)(cid:7)(cid:15)(cid:17)(cid:10)(cid:2)(cid:11)(cid:16)(cid:6)(cid:15)(cid:2)(cid:3)(cid:18)(cid:13)(cid:9)(cid:18)(cid:5)(cid:6)(cid:8)(cid:17)(cid:14)(cid:17)(cid:3)
`
`Foresight Diagnostics v. Personalis
`IPR2023-00224 and IPR2023-00317
`Alex de Winter of Mohr Davidow Ventures. See July 18, 2012 Meeting Minutes,
`
`EX2073, at page 1.
`
`35.
`
`I was the chairman of the meeting. See July 18, 2012 Meeting Minutes,
`
`EX2073, at page 3.
`
`36. The Minutes of the Meeting state that “[m]embers of management
`
`reported on, and discussed with those present, progress in the development of the
`
`Company’s business, planning for 2012 and 2013, recent financial performance
`
`compared to the original plan and preliminary strategy for the Company’s next
`
`financing.” See July 18, 2012 Meeting Minutes, EX2073, at page 1. Mr. West gave
`
`his CEO Overview presentation during the meeting. Dr. Chen gave his R&D Update
`
`presentation during the meeting.
`
`E.
`
`Summary of the September 5, 2012 Personalis Board of Director
`Meeting
`
`37. Exhibit 2087 appears to be a true and correct copy of the Minutes of the
`
`Meeting of the Board of Directors of Personalis, Inc. held on September 5, 2012.
`
`38. The September 5, 2012 Board of Director Meeting took place at 9:00am
`
`at the company office of Personalis located at 1350 Willow Road, Suite 202, Menlo
`
`Park, CA. See September 5, 2012 Meeting Minutes, EX2087, at page 1.
`
`39.
`
`I was present at the meeting along with Chris Schaepe of Lightspeed
`
`Venture Partners and Rowan Chapman of Mohr Davidow Ventures. Euan Ashley
`
`was present. Also present from Personalis were John West, Carol Tillis, and
`
`-8-
`
`Personalis EX2033
`
`
`
`(cid:16)(cid:27)(cid:21)(cid:29)(cid:20)(cid:24)(cid:23)(cid:26)(cid:1)(cid:17)(cid:26)(cid:30)(cid:22)(cid:25)(cid:27)(cid:28)(cid:22)(cid:1)(cid:19)(cid:16)(cid:12)(cid:1)(cid:4)(cid:10)(cid:16)(cid:18)(cid:5)(cid:4)(cid:4)(cid:14)(cid:2)(cid:15)(cid:6)(cid:14)(cid:3)(cid:2)(cid:7)(cid:15)(cid:17)(cid:10)(cid:2)(cid:11)(cid:16)(cid:6)(cid:15)(cid:2)(cid:3)(cid:18)(cid:13)(cid:9)(cid:18)(cid:5)(cid:6)(cid:8)(cid:17)(cid:14)(cid:17)(cid:3)
`
`Foresight Diagnostics v. Personalis
`IPR2023-00224 and IPR2023-00317
`Christian Haudenschild. Others present were Robin Bennett of Cooley LLP and
`
`Alex de Winter of Mohr Davidow Ventures. Jon Feiber of Mohr Davidow Ventures
`
`attended part of the meeting. See September 5, 2012 Meeting Minutes, EX2087, at
`
`page 1. Richard Chen also attended the meeting. See id. at page 2.
`
`40.
`
`I was the chairman of the meeting. See September 5, 2012 Meeting
`
`Minutes, EX2087, at page 2.
`
`41. The Minutes of the Meeting state that “[m]embers of management
`
`reported on, and discussed with those present, progress in the development of the
`
`Company’s business, recent financial performance compared to the original plan and
`
`preliminary strategy for the Company’s next financing.” See September 5, 2012
`
`Meeting Minutes, EX2087, at page 1. Mr. West gave his CEO Overview
`
`presentation during the meeting. Dr. Chen gave his R&D Update presentation
`
`during the meeting.
`
`F.
`
`Summary of the November 1, 2012 Personalis Board of Director Meeting
`
`42. Exhibit 2111 appears to be a true and correct copy of all three pages of
`
`the Minutes of the Meeting of the Board of Directors of Personalis, Inc. held on
`
`November 1, 2012. However, Exhibit 2111 does not include Exhibit A to the
`
`Minutes of the Meeting (which consists of a single page) because Exhibit A solely
`
`describes the confidential grant of Personalis stock options to certain employees of
`
`Personalis and an advisor of Personalis.
`
`-9-
`
`Personalis EX2033
`
`
`
`(cid:16)(cid:27)(cid:21)(cid:29)(cid:20)(cid:24)(cid:23)(cid:26)(cid:1)(cid:17)(cid:26)(cid:30)(cid:22)(cid:25)(cid:27)(cid:28)(cid:22)(cid:1)(cid:19)(cid:16)(cid:12)(cid:1)(cid:4)(cid:10)(cid:16)(cid:18)(cid:5)(cid:4)(cid:4)(cid:14)(cid:2)(cid:15)(cid:6)(cid:14)(cid:3)(cid:2)(cid:7)(cid:15)(cid:17)(cid:10)(cid:2)(cid:11)(cid:16)(cid:6)(cid:15)(cid:2)(cid:3)(cid:18)(cid:13)(cid:9)(cid:18)(cid:5)(cid:6)(cid:8)(cid:17)(cid:14)(cid:17)(cid:3)
`
`Foresight Diagnostics v. Personalis
`IPR2023-00224 and IPR2023-00317
`43. The November 1, 2012 Board of Director Meeting took place at 9:00am
`
`at the company office of Personalis located at 1350 Willow Road, Suite 202, Menlo
`
`Park, CA. See November 1, 2012 Meeting Minutes, EX2111, at page 1.
`
`44.
`
`I was present at the meeting along with Chris Schaepe of Lightspeed
`
`Venture Partners. Also present from Personalis were John West, Carol Tillis,
`
`Richard Chen, and Christian Haudenschild. Others present were Jim Kitch of
`
`Cooley LLP, Alex de Winter of Mohr Davidow Ventures, and Jon Feiber of Mohr
`
`Davidow Ventures. See November 1, 2012 Meeting Minutes, EX2111, at page 1.
`
`45.
`
`I was the chairman of the meeting. See November 1, 2012 Meeting
`
`Minutes, EX2111, at page 3.
`
`46. The Minutes of the Meeting state that “Mr. West provided an overview
`
`of the condition, position and prospects of the Company.” See November 1, 2012
`
`Meeting Minutes, EX2111, at page 2.
`
`G.
`
`Summary of the December 14, 2012 Personalis Board of Director
`Meeting
`
`47. Exhibit 2107 appears to be a true and correct copy of all three pages of
`
`the Minutes of the Meeting of the Board of Directors of Personalis, Inc. held on
`
`December 14, 2012. However, Exhibit 2107 does not include Exhibit A to the
`
`Minutes of the Meeting (which consists of a single page) because Exhibit A solely
`
`describes the confidential grant of Personalis stock options to certain new employees
`
`of Personalis.
`
`-10-
`
`Personalis EX2033
`
`
`
`(cid:16)(cid:27)(cid:21)(cid:29)(cid:20)(cid:24)(cid:23)(cid:26)(cid:1)(cid:17)(cid:26)(cid:30)(cid:22)(cid:25)(cid:27)(cid:28)(cid:22)(cid:1)(cid:19)(cid:16)(cid:12)(cid:1)(cid:4)(cid:10)(cid:16)(cid:18)(cid:5)(cid:4)(cid:4)(cid:14)(cid:2)(cid:15)(cid:6)(cid:14)(cid:3)(cid:2)(cid:7)(cid:15)(cid:17)(cid:10)(cid:2)(cid:11)(cid:16)(cid:6)(cid:15)(cid:2)(cid:3)(cid:18)(cid:13)(cid:9)(cid:18)(cid:5)(cid:6)(cid:8)(cid:17)(cid:14)(cid:17)(cid:3)
`
`Foresight Diagnostics v. Personalis
`IPR2023-00224 and IPR2023-00317
`48. The December 14, 2012 Board of Director Meeting took place at
`
`8:00am at the company office of Personalis located at 1350 Willow Road, Suite 202,
`
`Menlo Park, CA. See December 14, 2012 Meeting Minutes, EX2107, at page 1.
`
`49.
`
`I was present at the meeting along with Jon Feiber of Mohr Davidow
`
`Ventures. Also present from Personalis were John West, Carol Tillis, Richard Chen,
`
`and Christian Haudenschild. Jim Kitch of Cooley LLP was present as well. See
`
`December 14, 2012 Meeting Minutes, EX2107, at page 1.
`
`50.
`
`I was the chairman of the meeting. See December 14, 2012 Meeting
`
`Minutes, EX2107, at page 3.
`
`51. The Minutes of the Meeting state that “a review of the Company’s
`
`business that included discussion of the Company’s product plans, prospective
`
`customers, early financial planning for 2013 and the state of the markets being
`
`targeted by the Company.” See December 14, 2012 Meeting Minutes, EX2107, at
`
`page 2. Mr. West gave his CEO Overview presentation during the meeting. Dr.
`
`Chen gave his R&D Update presentation during the meeting.
`
`-11-
`
`Personalis EX2033
`
`
`
`(cid:16)(cid:27)(cid:21)(cid:29)(cid:20)(cid:24)(cid:23)(cid:26)(cid:1)(cid:17)(cid:26)(cid:30)(cid:22)(cid:25)(cid:27)(cid:28)(cid:22)(cid:1)(cid:19)(cid:16)(cid:12)(cid:1)(cid:4)(cid:10)(cid:16)(cid:18)(cid:5)(cid:4)(cid:4)(cid:14)(cid:2)(cid:15)(cid:6)(cid:14)(cid:3)(cid:2)(cid:7)(cid:15)(cid:17)(cid:10)(cid:2)(cid:11)(cid:16)(cid:6)(cid:15)(cid:2)(cid:3)(cid:18)(cid:13)(cid:9)(cid:18)(cid:5)(cid:6)(cid:8)(cid:17)(cid:14)(cid:17)(cid:3)
`
`Foresight Diagnostics v. Personalis
`IPR2023-00224 and IPR2023-00317
`III. CERTIFICATION
`52.
`I declare that all statements made herein of my own knowledge are true
`
`and that all statements made on information and belief are believed to be true; and
`
`further that these statements were made with the knowledge that willful false
`
`statements and the like so made are punishable by fine or imprisonment, or both,
`
`under Section 1001 of Title 18 of the United States Code.
`
`
`Dated:
`
`(cid:3)(cid:2)(cid:1)(cid:6)(cid:1)(cid:4)(cid:2)(cid:4)(cid:5)
`
`
`
`By:
`
`
`
`Jonathan MacQuitty, Ph.D.
`
`
`
`
`
`-12-
`
`Personalis EX2033
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
